DSM Firmenich Shares Rise on Accelerating Sales Growth and Margin Improvement

Shares of DSM Firmenich rose sharply after the nutrition and beauty group reported accelerating sales growth and improved profitability in its first-half 2026 results, signaling positive momentum heading into the second half of the year.

Accelerating Growth in Q2

The company announced that its like-for-like sales grew by 6% in the second quarter of 2026, an acceleration from the 4% growth seen in the first quarter. According to the release, performance was particularly strong in June, which the company attributed to improving customer sentiment as certain geopolitical concerns eased.

On a profitability basis, DSM Firmenich posted a 10% increase in like-for-like Adjusted EBITDA for the second quarter. The Adjusted EBITDA margin also improved by 40 basis points compared to the first quarter of 2026. However, the company noted that unfavorable foreign exchange rates continued to be a headwind for its reported margins.

Ad

Capital Returns and Market Context

Adding to investor confidence, the company's ongoing €540 million share repurchase program is well underway. As of late July, the program was approximately 62% complete, underscoring a continued commitment to shareholder returns.

The stock's advance was driven by these company-specific fundamentals rather than broader market trends. Major U.S. indices were nearly flat, indicating that investors were reacting directly to the strength of the earnings report. While the company's shares are available on the U.S. OTC market (DSMFF), significant price discovery and volume occur on its primary listing on the Euronext Amsterdam exchange.